| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 14, 2026 | Tax withholding(F) | 1K | $1.92 | $2K | 2.1M |
| May 14, 2026 | Tax withholding(F) | 490 | $1.92 | $941 | 314K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-002498) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Acrivon Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.